Fitzgerald Richard F 4
4 · Immunome Inc. · Filed Oct 5, 2020
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Fitzgerald Richard F
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-10-01+7,681→ 7,681 totalExercise: $12.00Exp: 2030-10-01→ Common Stock (7,681 underlying) - Award
Employee Stock Option (right to buy)
2020-10-01+104,802→ 104,802 totalExercise: $12.00Exp: 2030-10-01→ Common Stock (104,802 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The shares subject to the option shall vest on October 1, 2025, subject to the Reporting Person continuing to provide service through each such date.